| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Sep 20, 2024 | Sale | $6.53 | 1,132,566 | 7,395,203 | 5,099,336 | Sep 24, 2024, 04:40 PM | |
| GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Sep 13, 2024 | Sale | $6.16 | 9,269 | 57,100 | 6,231,902 | Sep 13, 2024, 06:44 PM | |
| GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Sep 11, 2024 | Sale | $6.00 | 541,897 | 3,251,382 | 6,257,218 | Sep 13, 2024, 06:44 PM | |
| GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Sep 12, 2024 | Sale | $6.00 | 16,047 | 96,309 | 6,241,171 | Sep 13, 2024, 06:44 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Aug 28, 2024 | Sale | $6.32 | 221,600 | 1,400,556 | 3,726,341 | Aug 30, 2024, 04:16 PM | |
| TPST | Tempest Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Aug 08, 2024 | Sale | $1.35 | 400,000 | 540,040 | 597,940 | Aug 12, 2024, 08:33 PM | |
| TPST | Tempest Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Aug 12, 2024 | Sale | $1.10 | 387,999 | 426,993 | 209,941 | Aug 12, 2024, 08:33 PM | |
| IPSC | Century Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Aug 09, 2022 | Sale | $13.03 | 550,000 | 7,166,610 | 11,816,814 | Aug 11, 2022, 04:55 PM | |
| RPTX | Repare Therapeutics Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jun 03, 2022 | Sale | $12.25 | 750,000 | 9,188,775 | 2,344,451 | Jun 07, 2022, 04:36 PM | |
| OYST | Oyster Point Pharma, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 18, 2021 | Sale | $14.84 | 550,000 | 8,160,736 | 1,057,976 | Oct 20, 2021, 04:38 PM | |
| GRPH | Graphite Bio, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jun 29, 2021 | Buy | $17.00 | 180,000 | 3,060,000 | 1,707,719 | Jul 01, 2021, 07:01 PM | |
| GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jun 28, 2021 | Buy | $19.00 | 157,895 | 3,000,005 | 2,097,938 | Jun 30, 2021, 05:00 PM | |
| IPSC | Century Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jun 22, 2021 | Buy | $20.00 | 100,000 | 2,000,000 | 714,095 | Jun 23, 2021, 04:30 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 30, 2020 | Sale | $33.15 | 10,393 | 344,513 | 874,299 | Dec 01, 2020, 07:13 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 19, 2020 | Sale | $33.01 | 114,854 | 3,791,330 | 4,818,600 | Nov 23, 2020, 04:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 19, 2020 | Sale | $33.01 | 15,163 | 500,531 | 968,954 | Nov 23, 2020, 04:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 18, 2020 | Sale | $33.09 | 63 | 2,085 | 984,117 | Nov 19, 2020, 09:19 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 17, 2020 | Sale | $33.05 | 3,705 | 122,450 | 4,933,927 | Nov 19, 2020, 09:19 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 17, 2020 | Sale | $33.05 | 489 | 16,161 | 984,180 | Nov 19, 2020, 09:19 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 18, 2020 | Sale | $33.09 | 473 | 15,653 | 4,933,454 | Nov 19, 2020, 09:19 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 13, 2020 | Sale | $33.77 | 525 | 17,731 | 984,890 | Nov 17, 2020, 07:33 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 16, 2020 | Sale | $33.01 | 177 | 5,843 | 4,937,632 | Nov 17, 2020, 07:33 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 16, 2020 | Sale | $33.01 | 23 | 759 | 984,669 | Nov 17, 2020, 07:33 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 13, 2020 | Sale | $33.77 | 3,975 | 134,253 | 4,939,311 | Nov 17, 2020, 07:33 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 12, 2020 | Sale | $34.15 | 13,779 | 470,526 | 4,951,587 | Nov 13, 2020, 07:47 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 12, 2020 | Sale | $34.15 | 1,819 | 62,116 | 986,512 | Nov 13, 2020, 07:47 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 11, 2020 | Sale | $34.73 | 11,146 | 387,127 | 5,655,404 | Nov 12, 2020, 05:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 11, 2020 | Sale | $34.73 | 1,471 | 51,091 | 988,227 | Nov 12, 2020, 05:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 10, 2020 | Sale | $33.83 | 23,821 | 805,755 | 5,669,956 | Nov 12, 2020, 05:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 10, 2020 | Sale | $33.83 | 3,145 | 106,381 | 990,149 | Nov 12, 2020, 05:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 06, 2020 | Sale | $33.13 | 362 | 11,993 | 992,387 | Nov 10, 2020, 07:24 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 09, 2020 | Sale | $33.06 | 5,565 | 183,954 | 5,681,344 | Nov 10, 2020, 07:24 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 09, 2020 | Sale | $33.06 | 735 | 24,296 | 991,652 | Nov 10, 2020, 07:24 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 06, 2020 | Sale | $33.13 | 2,738 | 90,706 | 5,686,909 | Nov 10, 2020, 07:24 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2020 | Sale | $33.14 | 2,208 | 73,164 | 5,697,463 | Nov 06, 2020, 04:44 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2020 | Sale | $33.14 | 292 | 9,676 | 993,781 | Nov 06, 2020, 04:44 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 05, 2020 | Sale | $33.15 | 7,816 | 259,079 | 5,689,647 | Nov 06, 2020, 04:44 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Nov 05, 2020 | Sale | $33.15 | 1,032 | 34,208 | 992,749 | Nov 06, 2020, 04:44 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 27, 2020 | Sale | $33.03 | 93 | 3,072 | 994,073 | Oct 28, 2020, 05:58 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 26, 2020 | Sale | $33.30 | 7,158 | 238,394 | 5,700,378 | Oct 28, 2020, 05:58 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 26, 2020 | Sale | $33.30 | 945 | 31,473 | 994,166 | Oct 28, 2020, 05:58 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 27, 2020 | Sale | $33.03 | 707 | 23,354 | 5,699,671 | Oct 28, 2020, 05:58 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 19, 2020 | Sale | $33.43 | 494 | 16,515 | 995,111 | Oct 20, 2020, 08:09 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 15, 2020 | Sale | $33.03 | 2,473 | 81,694 | 5,718,972 | Oct 20, 2020, 08:09 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 15, 2020 | Sale | $33.03 | 327 | 10,802 | 996,621 | Oct 20, 2020, 08:09 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 16, 2020 | Sale | $33.57 | 7,697 | 258,410 | 5,711,275 | Oct 20, 2020, 08:09 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 16, 2020 | Sale | $33.57 | 1,016 | 34,110 | 995,605 | Oct 20, 2020, 08:09 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 19, 2020 | Sale | $33.43 | 3,739 | 124,998 | 5,707,536 | Oct 20, 2020, 08:09 PM | |
| ALGS | Aligos Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 20, 2020 | Buy | $15.00 | 200,000 | 3,000,000 | 862,444 | Oct 20, 2020, 04:58 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 13, 2020 | Sale | $33.39 | 10,370 | 346,271 | 5,726,304 | Oct 15, 2020, 07:22 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 13, 2020 | Sale | $33.39 | 1,369 | 45,713 | 997,590 | Oct 15, 2020, 07:22 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 14, 2020 | Sale | $33.09 | 4,859 | 160,787 | 5,721,445 | Oct 15, 2020, 07:22 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 14, 2020 | Sale | $33.09 | 642 | 21,244 | 996,948 | Oct 15, 2020, 07:22 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 12, 2020 | Sale | $33.11 | 353 | 11,687 | 5,736,674 | Oct 13, 2020, 07:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 08, 2020 | Sale | $33.47 | 16,276 | 544,814 | 5,748,886 | Oct 13, 2020, 07:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 12, 2020 | Sale | $33.11 | 47 | 1,556 | 998,959 | Oct 13, 2020, 07:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 08, 2020 | Sale | $33.47 | 2,149 | 71,934 | 1,000,571 | Oct 13, 2020, 07:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 09, 2020 | Sale | $33.67 | 3,357 | 113,018 | 5,737,027 | Oct 13, 2020, 07:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 09, 2020 | Sale | $33.67 | 443 | 14,914 | 999,006 | Oct 13, 2020, 07:41 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 06, 2020 | Sale | $33.26 | 15,980 | 531,477 | 5,781,250 | Oct 08, 2020, 07:14 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 06, 2020 | Sale | $33.26 | 2,110 | 70,176 | 1,044,452 | Oct 08, 2020, 07:14 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 07, 2020 | Sale | $33.56 | 24,590 | 825,154 | 5,756,660 | Oct 08, 2020, 07:14 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Oct 07, 2020 | Sale | $33.56 | 3,246 | 108,924 | 1,041,206 | Oct 08, 2020, 07:14 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Aug 11, 2020 | Sale | $33.08 | 6,692 | 221,380 | 6,797,230 | Aug 12, 2020, 07:57 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Aug 11, 2020 | Sale | $33.08 | 883 | 29,211 | 1,125,778 | Aug 12, 2020, 07:57 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Aug 10, 2020 | Sale | $33.04 | 5,492 | 181,446 | 6,803,922 | Aug 12, 2020, 07:57 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Aug 10, 2020 | Sale | $33.04 | 725 | 23,953 | 1,126,661 | Aug 12, 2020, 07:57 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 07, 2020 | Sale | $20.05 | 14,162 | 283,948 | 2,885,836 | Jul 10, 2020, 08:28 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 08, 2020 | Sale | $19.80 | 22,368 | 442,886 | 2,863,468 | Jul 10, 2020, 08:28 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 09, 2020 | Sale | $20.21 | 16,527 | 334,011 | 2,846,941 | Jul 10, 2020, 08:28 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 02, 2020 | Sale | $20.36 | 15,852 | 322,685 | 3,645,633 | Jul 10, 2020, 08:28 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 03, 2020 | Sale | $19.21 | 3,200 | 61,485 | 2,953,490 | Jul 10, 2020, 08:28 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 06, 2020 | Sale | $19.54 | 53,392 | 1,043,102 | 2,948,422 | Jul 10, 2020, 08:28 PM | |
| RPTX | Repare Therapeutics Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jun 23, 2020 | Buy | $20.00 | 250,000 | 5,000,000 | 3,419,451 | Jun 25, 2020, 06:46 PM | |
| PASG | Passage BIO, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Mar 03, 2020 | Buy | $18.00 | 225,000 | 4,050,000 | 933,352 | Mar 03, 2020, 07:03 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Feb 03, 2020 | Buy | $19.00 | 396,082 | 7,525,558 | 6,809,414 | Feb 05, 2020, 06:02 PM | |
| BDTX | Black Diamond Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Feb 03, 2020 | Buy | $19.00 | 498,654 | 9,474,426 | 2,209,592 | Feb 05, 2020, 06:02 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 16, 2020 | Sale | $19.72 | 22,489 | 443,483 | 3,129,741 | Jan 21, 2020, 09:57 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 17, 2020 | Sale | $20.09 | 11,103 | 223,059 | 3,118,638 | Jan 21, 2020, 09:57 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 21, 2020 | Sale | $22.20 | 25,940 | 575,861 | 3,110,547 | Jan 21, 2020, 09:57 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 15, 2020 | Sale | $19.73 | 7,511 | 148,192 | 3,152,230 | Jan 15, 2020, 09:53 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 10, 2020 | Sale | $20.10 | 19,343 | 388,794 | 3,183,724 | Jan 15, 2020, 09:53 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 13, 2020 | Sale | $20.16 | 11,676 | 235,445 | 3,172,131 | Jan 15, 2020, 09:53 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 14, 2020 | Sale | $20.00 | 12,307 | 246,140 | 3,159,741 | Jan 15, 2020, 09:53 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 08, 2020 | Sale | $19.80 | 22,368 | 442,886 | 3,219,594 | Jan 09, 2020, 08:11 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 09, 2020 | Sale | $20.21 | 16,527 | 334,011 | 3,203,067 | Jan 09, 2020, 08:11 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 07, 2020 | Sale | $20.05 | 14,162 | 283,948 | 3,241,962 | Jan 09, 2020, 08:11 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 02, 2020 | Sale | $20.36 | 15,852 | 322,685 | 4,001,759 | Jan 06, 2020, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 03, 2020 | Sale | $19.21 | 3,200 | 61,485 | 3,309,616 | Jan 06, 2020, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Jan 06, 2020 | Sale | $19.54 | 53,392 | 1,043,102 | 3,304,548 | Jan 06, 2020, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 31, 2019 | Sale | $23.48 | 17,207 | 404,020 | 3,656,585 | Dec 31, 2019, 07:11 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 27, 2019 | Sale | $22.58 | 33,256 | 750,920 | 4,012,711 | Dec 31, 2019, 07:11 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 30, 2019 | Sale | $24.39 | 338,919 | 8,266,234 | 3,673,792 | Dec 31, 2019, 07:11 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 27, 2019 | Sale | $22.58 | 33,256 | 750,920 | 4,012,711 | Dec 31, 2019, 06:05 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 30, 2019 | Sale | $24.39 | 338,919 | 8,266,234 | 3,673,792 | Dec 31, 2019, 06:05 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 31, 2019 | Sale | $23.48 | 17,207 | 404,020 | 3,656,585 | Dec 31, 2019, 06:05 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 26, 2019 | Sale | $22.48 | 23,600 | 530,528 | 4,045,967 | Dec 26, 2019, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 20, 2019 | Sale | $19.80 | 18,582 | 367,924 | 4,076,605 | Dec 26, 2019, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 23, 2019 | Sale | $21.56 | 5,433 | 117,135 | 4,071,172 | Dec 26, 2019, 08:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | Dec 24, 2019 | Sale | $21.70 | 1,605 | 34,829 | 4,069,567 | Dec 26, 2019, 08:59 PM |
Menu